Peter Domaille has joined San Diego-based GeneFormatics as director of structural biolog, the company said last week. Domaille will direct the company’s structural biology programs and NMR development efforts, as well as oversee the company’s collaborations with various Bruker divisions, which are primarily focused on using high-field NMR spectrometers to determine protein structure. He was previously director of biomolecular NMR at DuPont Pharmaceuticals, and has worked at E.I. Du Pont du Nemours Research and Development and DuPont Merck Pharmaceutical Research and Development.
Cognia has made three appointments designed to strengthen the company’s proteomics information technology efforts. Brian Osborne has joined the company as director of informatics. He was previously in charge of information technology and bioinformatics at Cadus Pharmaceuticals and OSI Pharmaceuticals. In addition, he previously worked on genome annotation and bioinformatics in the Arabidopsis genome initiative. Cognia hired Grace Stafford as curation manager. She was previously in Incyte Genomics’ Proteome division, where she worked on a project to annotate mammalian proteome databases. The company also added Robert Merold to its board of directors. Merold is executive-in-residence at Boston Millennia Partners. He was previously chief operating officer at Proteome, which was acquired by Incyte Genomics.
Amersham Biosciences and Science magazine have begun soliciting submissions for the 2002 Amersham Biosciences and Science Prize for young scientists. Established in 1995, the prize is open to scientists who completed a PhD in molecular biology during 2001. The grand prize winner will have his or her thesis paper published in Science, and receive $25,000. Entrants must submit a 1,000-word essay and an entry form, which can be found at www.amershamscienceprize.org. Materials must be submitted in English, French, German, Spanish, Japanese, or Chinese (Mandarin). The deadline for entries is July 15, 2002.